Latest Report Available at Orbis research New Drug Delivery Systems Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/219661 .
The European NDDS market is estimated to hit USD 40 billion in 2014 and is expected to grow at a CAGR of 8.15% during the forecast period 2014-2020
The European market for NDDS is the second largest in the world, accounting for close to 30 % of the global market share. The requirements for innovative drug delivery have led to the need for controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs, in turn leading to the birth of drug delivery systems.
Unprecedented developments in genomics and molecular biology today offer a plethora of new drug targets. The method by which a drug is delivered to these targets can have a significant impact on its efficacy. The industries have diverted their research focus from the conventional dosage forms to novel drug delivery technologies that have significantly improved market requirements. In the recent years, the pharmaceutical companies have been struggling to maintain a balance between the pressure to drop prices and the high innovation costs. It is always advantageous for companies to develop their own innovative delivery devices to maintain a lead in the market.
EuropeNDDS market has been segmented by the mode of delivery and region. By the mode of delivery, the market has been segmented into oral, pulmonary, transdermal and injectable drug delivery systems. These are further segmented by their modes of administration. By region, the market has been segmented into the UK, Germany, France, Switzerland, Spain and the Rest of Europe.
Purchase a copy of New Drug Delivery Systems Market visit @ http://www.orbisresearch.com/contact/purchase/219661 For more information contact sales@orbisresearch.com .
Some of the key players in the market are:
Activaero
Innocore Pharmaceuticals
Medgenesis Therapeutix
Merck & Co.
Merrion Pharmaceuticals
Roche
What the Report Offers
Market definition for the European NDDS market along with identification of key drivers and restraints for the market.
Market analysis for the European NDDS market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
Identification and analysis of the macro and micro factors that affect the European NDDS market on both global and regional scale.
A comprehensive list of the key market players along with the analysis of their current strategic interests and key financial information.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/europe-new-drug-delivery-systems-market-analysis-and-forecast-2017-2022 .
Some points From Toc:
- Introduction
- Market Definition
- Market Drivers
- Market Restraints
- New drug delivery systems
5.1 Overview
5.2 Market segmentation by mode of delivery
5.2.1 Oral Delivery Devices
Advantages
Challenges
5.2.1.1 Segmentation based on mode of action
1. Dissolution controlled release systems
2. Diffusion controlled release systems
3. Dissolution and diffusion controlled release systems
4. Osmotic pressure controlled systems
5. PH-Independent formulations
6. Ion-exchange resin-drug complexes
7. Slow dissolving salts and complexes
8. Hydrodynamic pressure controlled system
5.2.2 Pulmonary Drug Delivery Devices
Advantages
Challenges
5.2.2.1 Segmentation By mode of administration
1. Inhalation drug delivery system by metered dose inhalers
2. Inhalation drug delivery system by dry powder inhalers
3. Inhalation drug delivery system by nebulizer
5.2.3 Transdermal Drug delivery systems
Advantages
Challenges
5.2.3.1 Segmentation by mode of administration
1. Iontophoresis
2. Electroporation
3. Application by ultrasound
4. Use of microscopic projection
5.2.3.2 Types of Transdermal patches
1. Single layer drug in adhesive
2. Multilayer drug in adhesive
3. Reservoir
4. Matrix
5. Vapour patch
5.2.4 Injectable Drug Delivery system
Advantages
Challenges
5.2.4.1 Segmentation by mode of administration
1. Subcutaneous injection
2. Intramuscular injection
3. Intravenous injection
4. Intradermal injection
5. Intraperitoneal injection
6. Upcoming Delivery Technologies
1. Microsponges
2. Nanotechnology
3. Immunoconjugates
4. Virus
5. Micro and Nano Emulsions
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment